Biotech Values

[10nisman]

As Wallstarb said the the cash is nice but it won't move the price much unless it goes on for 2+ years. People should have listened to him and not Dew. They would have been much better off.

Let's see... Dew recommended buying MNTA when it was trading around $5-6/share while Wallstarb was short MNTA going into MNTA's FDA Lovenox approval announcement. I'll take my profits from following Dew vs. Wallstarb's shorting loss. How quickly people ignore the real facts.

10nis